Home/Filings/4/0001209191-23-001028
4//SEC Filing

Hill Christopher Scott 4

Accession 0001209191-23-001028

CIK 0001000229other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:55 PM ET

Size

9.2 KB

Accession

0001209191-23-001028

Insider Transaction Report

Form 4
Period: 2022-12-31
Hill Christopher Scott
Chief Accounting Officer
Transactions
  • Tax Payment

    Common Shares

    2022-12-31$20.27/sh12,470$252,76750,172 total
  • Exercise/Conversion

    Common Shares

    2022-12-31+31,68862,642 total
  • Exercise/Conversion

    Performance Shares

    2022-12-3131,6880 total
    Exercise: $0.00Common Shares (31,688 underlying)
Holdings
  • Common Shares

    (indirect: By 401(k))
    59
Footnotes (1)
  • [F1]These shares were awarded as restricted performance shares in February 2020, as disclosed in the Reporting Person's Form 4 filing on February 12, 2020. All requirements for 100% vesting have been met and thus the restricted shares vested on December 31, 2022 at the conclusion of the performance period.

Issuer

CORE LABORATORIES N V

CIK 0001000229

Entity typeother

Related Parties

1
  • filerCIK 0001641315

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:55 PM ET
Size
9.2 KB